Drug Profile
Rifalazil controlled release
Alternative Names: Rifalazil GRLatest Information Update: 20 Aug 2018
Price :
$50
*
At a glance
- Originator ActivBiotics; Depomed
- Class Antituberculars; Rifamycins
- Mechanism of Action DNA-directed RNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Helicobacter infections
Most Recent Events
- 15 Aug 2018 Depomed is now called Assertio Therapeutics
- 30 Jun 2004 Discontinued - Preclinical for Helicobacter infections in USA (PO)
- 07 Apr 2004 This compound is still in active development - (BioSquare-2004)